Search results for Exparel

Real-World Data on EXPAREL® Shows Reduced Opioid Use and Lower Total Medical Costs in Medicare Patients Undergoing Tota...

How Plastic Surgeons Are Rethinking Post-Op Pain Management

As interest in opioid-sparing recovery strategies grows, Alexander Zuriarrain, MD, FACS, discusses how multimodal pain management and long-acting local anesthetics are reshaping po...

Nanotechnology-Based Device Reduces Pain and Immediate Opioid Requirements, and Facilitates Earlier Discharge from the H...

Opioids are often used to control pain following total knee arthroplasty (TKA). Opioid-sparing pain relief tools are needed in the current setting of the opioid crisis. This prospe...

PainTEQ Launches TRAQв„ў, A Next-Generation Posterior Approach to SI Joint Fusion

Fancy Pain Block, Familiar Result

In “failing” this study delivered an important pain management insight for total hip arthroplasty surgeons…

Extended oral tranexamic acid had similar pain scores vs. placebo

NEW ORLEANS — Results presented here showed no differences in pain scores, opioid consumption or functional outcomes among patients undergoing total knee arthroplasty who received...

Cerapedics Announces Supplier Agreement with Vizient for PearlMatrix® P-15 Peptide Enhanced Bone Graft

Agreement expands access to the Cerapedics portfolio of peptide-powered drug-device products for spinal fusion procedures WESTMINSTER, Colo., April 27,…

Pacira BioSciences, Inc. 2026 Q1 - Results - Earnings Call Presentation

Pacira BioSciences' CFO Sold 12,941 Shares for $326,000 Before Its Q1 Earnings Release

Pacira BioSciences, a leader in non-opioid pain management, reported a notable insider sale amid ongoing option exercise activity.

Cerapedics Announces Supplier Agreement with Vizient for PearlMatrixВ® P-15 Peptide Enhanced Bone Graft

Perioperative Administration of Mirogabalin for Postoperative Pain Management Following Total Hip Arthroplasty: A Random...

Mirogabalin, a selective α2δ-1 ligand, has been proposed to exhibit potent analgesic effects with fewer central nervous system (CNS) side effects than prior gabapentinoids. Its eff...

A year after Vertex’s big launch, pain drug research faces a pivotal moment

Journavx revived an area of development long considered a graveyard. Can any other pain drugs keep investor excitement going?

BioDelivery Sciences Int’l, Inc. v. Alvogen PB Research & Development LLC

This case was filed in 2018 when Alvogen submitted to the FDA an ANDA for approval to market generic Belbuca, a buprenorphine buccal film used to administer the drug transmucosally...

Oral Dexamethasone Versus Methylprednisolone Taper for Postoperative Pain and Recovery after Total Knee Arthroplasty

Systemic corticosteroids are playing an increasingly important role in elective total knee arthroplasty (TKA) to aid in postoperative recovery. Corticosteroids reduce inflammation...

Medtronic announces intent to acquire SPR Therapeutics, Inc., expanding care options for people living with chronic pain